FORM 8-K

Company

Oruka Therapeutics, Inc.

Filed

May 1, 2003

Period of Report

May 1, 2003

Accession Number

0000891618-03-002245

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →